Skip to main content
Year archive

PROCTER & GAMBLE HEALTH LIMITED — 2025 filings

All 137 regulatory filings released by PROCTER & GAMBLE HEALTH LIMITED (PGHL) in 2025, sourced directly from the official regulator.

137 Filings
2025 Period
2025 filings (137)
Filing Released Lang
Trading Window
Regulatory Filings
2025-12-26 English
Board Meeting — Financial Results
Regulatory Filings
2025-12-26 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-12-26 English
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve The meeting of the ....
Regulatory Filings
2025-12-26 English
Dear Sir, Please find attached intimation for closure of trading window for the quarter to be ended on December 31, 2025.
Regulatory Filings
2025-12-26 English
Dear Sir, Please find attached revised outcome of the postal ballot results declared on November 17, 2025, as advised by the exchange.
Board/Management Information
2025-11-18 English
Approval of shareholders for appointment of Mr. Shashank Srowthy as an Executive Director of the Company, via postal ballot.
Board/Management Information
2025-11-17 English
General Updates
Board/Management Information
2025-11-17 English
Voting results along with report of the scrutinizer for the postal ballot completed on November 16, 2025
Declaration of Voting Results & Voting Rights Announcements
2025-11-17 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2025-11-17 English
We enclose herewith Press Release regarding the unaudited financial results for quarter ended September 30, 2025.
Earnings Release Q2 2026
2025-11-05 English
Press Release
Earnings Release Q2 2026
2025-11-05 English
Outcome of Board Meeting
Interim / Quarterly Report Q1 2026
2025-11-05 English
Outcome of Board Meeting
Interim / Quarterly Report Q1 2026
2025-11-05 English
Outcome of Board Meeting held for the quarter ended September 30, 2025
Interim / Quarterly Report Q2 2026
2025-11-05 English
Outcome of Board Meeting for the quarter ended September 30, 2025
Interim / Quarterly Report Q2 2026
2025-11-05 English
Purpose of the meeting has been revised
Regulatory Filings
2025-10-20 English
Board Meeting — Financial Results
Regulatory Filings
2025-10-20 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-20 English
Please find attached report for the quarter ended September 30, 2025
Regulatory Filings
2025-10-20 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-10-20 English
Intimation of allotment of DIN to Mr. Shashank Srowthy, Executive Director
Board/Management Information
2025-10-01 English
General Updates
Board/Management Information
2025-10-01 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-09-29 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2025-09-29 English
Trading Window
Regulatory Filings
2025-09-29 English
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and approve Intimation of Board ....
Regulatory Filings
2025-09-29 English
Intimation for closure of Trading window for the quarter ended September 30, 2025
Regulatory Filings
2025-09-29 English
Resignation
Regulatory Filings
2025-09-16 English
Appointment
Regulatory Filings
2025-09-16 English
Change in senior management personnel of the Company
Board/Management Information
2025-09-16 English
Mr. Lokesh Chandak has stepped down as Chief Financial Officer of the Company as he will be moving onto his new assignment in P&G.
Board/Management Information
2025-09-16 English
Resignation
Board/Management Information
2025-09-16 English
Appointment of Mr. Shashank Srowthy as Executive Director and Chief Financial Officer of the Company, effective October 1, 2025 in place of Mr. Lokesh Chandak.
Board/Management Information
2025-09-16 English
Appointment
Board/Management Information
2025-09-16 English
Resignation
Board/Management Information
2025-09-16 English
Appointment
Board/Management Information
2025-09-16 English
Dear Sir, Please find attached intimation regarding change in senior management personnel of the Company
Board/Management Information
2025-09-08 English
Cessation
Board/Management Information
2025-09-08 English
Pursuant to Reg. 30 of the SEBI LODR, we hereby inform you that Mr. Ketan Kotadiya has been appointed as Head- Medical, Regulatory and R&D effective September 1, 2025.
Board/Management Information
2025-09-01 English
Appointment
Board/Management Information
2025-09-01 English
Please find attached proceedings of the annual general meeting held for financial year 2024-25
AGM Information
2025-08-29 English
Dear Sir, Please find attached voting results for the resolutions proposed to be passed at the Annual General meeting held today, along with scrutinizers report thereon.
Declaration of Voting Results & Voting Rights Announcements
2025-08-29 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2025-08-29 English
Shareholders meeting
Regulatory Filings
2025-08-29 English
General Updates
Notice of Dividend Amount
2025-08-25 English
Dear Sir, Please find attached intimation regarding IEPF''s 100 days campaign.
Regulatory Filings
2025-08-25 English
Dear Sir/Madam, Please find attached letter for re-submission of annual report, to reflect the same under regulation 34(1) compliance. Same was submitted earlier, on August 6th, as per ....
Annual Report FY 2025
2025-08-25 English
Dear Sir, Please note that the stock exchanges have today, approved the reclassification of Company''s promoters, pursuant to Company''s application dated June 27, 2018. Further ....
Major Shareholding Notification
2025-08-18 English
General Updates
Major Shareholding Notification
2025-08-18 English
Record date for the 58th Annual General Meeting and final dividend for FY 2024-25, if approved at the said AGM
Regulatory Filings
2025-08-06 English
Record Date
AGM Information
2025-08-06 English
Shareholders meeting
Regulatory Filings
2025-08-06 English
Dear Sir, Please find attached BRSR report for the Financial Year ended March 31, 2025.
Environmental & Social Information
2025-08-06 English
Dear Sir, Please find enclosed the Annual Report for the Financial Year 2024-25 and notice calling 58th Annual General Meeting of the Company
AGM Information
2025-08-06 English
Press Release for the quarter ended June 30, 2025
Earnings Release Q1 2026
2025-08-01 English
Please find attached unaudited financial results for quarter ended June 30, 2025.
Interim / Quarterly Report Q1 2026
2025-08-01 English
Press Release
Earnings Release Q1 2026
2025-08-01 English
Please find attached outcome of Board meeting dated August 1, 2025.
Interim / Quarterly Report Q1 2026
2025-08-01 English
Outcome of Board Meeting
Regulatory Filings
2025-08-01 English
Outcome of Board Meeting
Regulatory Filings
2025-08-01 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-07-15 English
Dear Sir, Please find attached certificate under regulation 74(5) of SEBI (DP) Regulations, for the quarter ended June 30, 2025
Regulatory Filings
2025-07-15 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2025-07-03 English
Change in Management
Board/Management Information
2025-06-27 English
Dear Sir, Please find attached intimation regarding change in senior management personnel of the Company.
Board/Management Information
2025-06-27 English
Trading Window
Regulatory Filings
2025-06-27 English
Board Meeting — Financial Results
Regulatory Filings
2025-06-27 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-06-27 English
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve Dear Sir, We would ....
Regulatory Filings
2025-06-27 English
Dear Sir, Please find attached intimation regarding closure of trading window of the Company for the quarter ended June 30, 2025.
Regulatory Filings
2025-06-27 English
Outcome of Board Meeting
Regulatory Filings
2025-06-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-06-17 English
Dear Sir, This has reference to the virtual connect with analysts/ institutional investors held on Monday, June 16, 2025 at 2:30 p.m. (IST). Pursuant to Regulation 30 of SEBI (Listing ....
Call Transcript
2025-06-17 English
Dear Sir, Please find attached presentation for analyst/institutional investors call scheduled for today, at 2.30 pm.
Regulatory Filings
2025-06-16 English
Investor Presentation
Regulatory Filings
2025-06-16 English
Cessation
Regulatory Filings
2025-06-11 English
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure requirement) regulations 2015, Mr. Siddhartha Vachaspati, shall cease to be Company''s sales leader effective June ....
Board/Management Information
2025-06-11 English
Dear Sir, Please find attached Company''s communication w.r.t. deduction of TDS on the amount of dividend proposed for final dividend for the financial year 2024-25, subject to approval ....
Notice of Dividend Amount
2025-06-09 English
Updates
Notice of Dividend Amount
2025-06-09 English
Dear Sir, Please find attached Company''s annual secretarial compliance report for the year ended March 31, 2025.
Regulatory Filings
2025-05-29 English
We wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors as per the enclosed mentioned. Institutional investors/Analysts ...
Regulatory Filings
2025-05-29 English
Find enclosed intimation on appointment of secretarial auditors for a period of five years.
Board/Management Information
2025-05-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-05-29 English
Find enclosed the press release on the audited financial results for the year ended March 31,2025.
Earnings Release FY 2025
2025-05-29 English
The Board of Directors at its meeting held today, have recommended a dividend of Rs. 45 per equity share for the FY ended March 31,2025.
Regulatory Filings
2025-05-29 English
Press Release
Earnings Release FY 2025
2025-05-29 English
Find enclosed financial results for the financial year ended March 31,2025.
Regulatory Filings
2025-05-29 English
We are pleased to inform you that a meeting of the Board of Directors of the Company held today (commenced at 12.40 pm and ended at 5.14 pm), the Audited Financial Results for the Financial ....
Regulatory Filings
2025-05-29 English
We are pleased to inform you that a meeting of the Board of Directors of the Company held today (commenced at 12.40 pm and ended at 5.14 pm), the Audited Financial Results for the Financial ....
Regulatory Filings
2025-05-29 English
General Updates
Board/Management Information
2025-05-29 English
General Updates
Regulatory Filings
2025-05-29 English
Dividend
Regulatory Filings
2025-05-29 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-04-14 English
Dear Sir, Please find attached disclosures under regulation 74 of SEBI (DP) Regulations, for the quarter ended March 31, 2025. Kindly take the same on record.
Regulatory Filings
2025-04-14 English
General Updates
Board/Management Information
2025-04-10 English
We are pleased to inform you that the shareholders of the Company have approved resolution for appointment of Mr. Sharad Tyagi and Ms. Krishna Sarma as Independent Director of the Company, ....
Board/Management Information
2025-04-10 English
Dear Sir, Please find attached proceedings of the postal ballot along with results and scrutinizers report. Request you to kindly take the same on record.
Declaration of Voting Results & Voting Rights Announcements
2025-04-10 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2025-04-10 English
Trading Window
Regulatory Filings
2025-03-26 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2025-03-26 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-03-26 English
Dear Sir, Please find attached intimation regarding closure of Company''s trading window for Directors and Designated employees.
Regulatory Filings
2025-03-26 English
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve In terms of Regulation ....
Regulatory Filings
2025-03-26 English
Dear Sir, Please find attached notice of postal ballot along with postal ballot form, for seeking approval of the members of the Company on the agenda items mentioned in the postal ballot notice.
Proxy Solicitation & Information Statement
2025-03-10 English
Shareholders meeting
Proxy Solicitation & Information Statement
2025-03-10 English
Integrated Filing- Financial
Regulatory Filings
2025-02-18 English
Dear Sir, Pursuant to SEBI circular dated December 31, 2024, we are hereby submitting integrated financial filing for the quarter and half year ended December 31, 2024. Request you ....
Interim / Quarterly Report H1 2025
2025-02-18 English
Integrated Filing- Financial
Regulatory Filings
2025-02-17 English
Updates
Notice of Dividend Amount
2025-02-13 English
Find enclosed the communication with respect to tax deduction at source on dividend income declared by the Company
Notice of Dividend Amount
2025-02-13 English
Find enclosed press release on the unaudited financial results for the quarter ended December 31,2024.
Earnings Release Q2 2025
2025-02-12 English
Find enclosed communication with respect to appointment of chairperson of the Board.
Regulatory Filings
2025-02-12 English
Find enclosed communication with respect to change in directorate-retirement
Regulatory Filings
2025-02-12 English
Find enclosed intimation with respect to change in directorate
Board/Management Information
2025-02-12 English
Find enclosed communication with respect to change in directorate
Board/Management Information
2025-02-12 English
Appointment
Regulatory Filings
2025-02-12 English
Find enclosed the communication with respect to interim dividend for the Fy 2024-25 declared at the meeting held today
Interim / Quarterly Report Q2 2025
2025-02-12 English
Appointment
Board/Management Information
2025-02-12 English
Appointment
Board/Management Information
2025-02-12 English
Find enclosed the unaudited financial results for the quarter ended December 31,2024
Interim / Quarterly Report Q2 2025
2025-02-12 English
Retirement
Regulatory Filings
2025-02-12 English
Find enclosed the unaudited financial results for the quarter ended December 31,2024 along with the limited review report and recommendation of interim dividend for the FY 2024-25
Regulatory Filings
2025-02-12 English
Press Release
Earnings Release Q2 2025
2025-02-12 English
Find enclosed the unaudited financial results for the quarter ended December 31,2024 along with the limited review report and recommendation of interim dividend for the FY 2024-25
Regulatory Filings
2025-02-12 English
Dividend
Regulatory Filings
2025-02-12 English
Record Date
Regulatory Filings
2025-02-12 English
Financial Result Updates
Regulatory Filings
2025-02-12 English
Dividend
Regulatory Filings
2025-02-12 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-31 English
Board Meeting — Financial Results/Dividend
Notice of Dividend Amount
2025-01-31 English
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Update on board meeting
Notice of Dividend Amount
2025-01-31 English
Dear Sir, This is to inform that the Board of Directors of the Company have approved today, the change of the Financial Year of the Company from "July 1st-June 30th" period to "April ....
Regulatory Filings
2025-01-23 English
Procter & Gamble Health Ltd has informed BSE regarding "Intimation regarding change of the Financial Year of the Company".
Regulatory Filings
2025-01-23 English
General Updates
Regulatory Filings
2025-01-23 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-01-09 English
Dear Sir, Please find attached confirmation of compliance under regulation 74 (5) of the SEBI (DP) Regulations, for the quarter ended December 31, 2024. Request you to kindly take ....
Regulatory Filings
2025-01-09 English